tickrz reports
  
tickrz rank
D
Dentsply Sirona Inc (XRAY)
Healthcare | Medical Instruments & Supplies
CEO: Jeffrey T. Slovin
Employees: 11400
DENTSPLY.com
FACTOR RANKINGSFACTOR SCREENER 
Pure Value Rank340Dividend Rank146
Moat Rank428Financial Strength Rank281
Growth Rank105Momentum Rank363
DIVIDEND ANALYSIS
Dividend Yield0.52%
Payout Ratio19.82%
3 yr Dividend Growth7.43%
VALUATION RATIOS
P/E Ratio39.54x
P/B Ratio1.77x
P/S Ratio3.72x
EV/EBITDA Ratio19.76x
FINANCIAL STRENGTH
Piotroski F-Score4
Debt-to-Equity19%
Interest Coverage13.44x
MOAT
ROE4.42%
ROIC4.08%
Net Margin11.48%
GROWTH
5 yr EPS Growth2.68%
5 yr SPS Growth8.1%
5 yr BPS Growth22%
Dentsply Sirona Inc 's strong growth translates to a Growth Rank in the top 25% of all stocks
 tickrz summary
Dentsply Sirona Inc receives a D ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
 value
 pure value ranking Warren Buffett ranking
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Dentsply Sirona Inc's valuation score is comprised of a P/E ratio of 39.5x, a P/B ratio of 1.8x, a P/S ratio of 3.7x, and an EV/EBITDA ratio of 19.8x. Dentsply Sirona Inc ranks 340 out of the S&P 500 constituents on valuation--a relatively weak score.Dentsply Sirona Inc ranks 422 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Dentsply Sirona Inc is probably not for you.

 quality
 moat financial strength
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.Dentsply Sirona Inc has a Piotroski F Score of 4 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 13.44x, a debt/equity ratio of 19% and a Moat Rank of 428 translate to an average Financial Strength score.


 momentum
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 3.38% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 363. Based on its 12 month stock performance, Dentsply Sirona Inc will not appeal to momentum investors.

 yield
 value + yield
Shares currently yield 0.52%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Dentsply Sirona Inc ranks 146 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

 growth
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 2.7% 5 year annualized EPS growth, 8.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 22% speak to its impressive growth ranking.

Dentsply Sirona Inc (XRAY)
Healthcare | Medical Instruments & Supplies
CEO: Jeffrey T. Slovin
Employees: 11400
DENTSPLY.com


tickrz rank
D

VALUATION RATIOS
P/E Ratio39.54x
P/B Ratio1.77x
P/S Ratio3.72x
EV/EBITDA Ratio19.76x
DIVIDEND ANALYSIS
Dividend Yield0.52%
Payout Ratio19.82%
3 yr Dividend Growth7.43%
FINANCIAL STRENGTH
Piotroski F-Score4
Debt-to-Equity19%
Interest Coverage13.44x
MOAT
ROE4.42%
ROIC4.08%
Net Margin11.48%
GROWTH
5 yr EPS Growth2.68%
5 yr SPS Growth8.1%
5 yr BPS Growth22%

TICKRZ RANK
Dentsply Sirona Inc receives a D ranking in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Dentsply Sirona Inc's valuation score is comprised of a P/E ratio of 39.5x, a P/B ratio of 1.8x, a P/S ratio of 3.7x, and an EV/EBITDA ratio of 19.8x. Dentsply Sirona Inc ranks 340 out of the S&P 500 constituents on valuation--a relatively weak score.

WARREN BUFFETT RANKING
Dentsply Sirona Inc ranks 422 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a weak score, meaning it ranks poorly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Dentsply Sirona Inc is probably not for you.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is weak. Its position within the Healthcare sector appears to be weak. Either the dynamics of its sector place it in a difficult position or management's executition is to blame for its disappointing performance.

FINANCIAL STRENGTH
Dentsply Sirona Inc has a Piotroski F Score of 4 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 13.44x, a debt/equity ratio of 19% and a Moat Rank of 428 translate to an average Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 3.38% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 363. Based on its 12 month stock performance, Dentsply Sirona Inc will not appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.52%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Dentsply Sirona Inc ranks 146 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 2.7% 5 year annualized EPS growth, 8.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 22% speak to its impressive growth ranking.